Detection of early subclinical lung disease in children with cystic fibrosis by lung ventilation imaging with hyperpolarised gas MRI

Thorax

Volumn 72, Issue 8, 2017, Pages 760-762

  Marshall, Helen ^a   Horsley, Alex ^a,b   Taylor, Chris J ^c   Smith, Laurie ^a,c   Hughes, David ^c   Horn, Felix C ^a   Swift, Andrew J ^a   Parra Robles, Juan ^a   Hughes, Paul J ^a   Norquay, Graham ^a   Stewart, Neil J ^a   Collier, Guilhem J ^a   Teare, Dawn ^d   Cunningham, Steve ^e   Aldag, Ina ^c   Wild, Jim M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Cystic Fibrosis; Imaging CT MRI etc; Respiratory Measurement

Indexed keywords

HELIUM; HYDROGEN;

ADOLESCENT; BREATHING DISORDER; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HYPERPOLARISED GAS VENTILATION MAGNETIC RESONANCE IMAGING; IMAGE ANALYSIS; LETTER; LUNG CLEARANCE; LUNG DISEASE; LUNG VENTILATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPIROMETRY; ARTIFICIAL VENTILATION; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; LUNG; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

ADOLESCENT; CHILD; CYSTIC FIBROSIS; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; MALE; RESPIRATION, ARTIFICIAL; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85021219355     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-208948     Document Type: Letter

References (10)

1. Horsley AR, Gustafsson PM, Macleod KA, et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 2008;63:135-40.
2. Bannier E, Cieslar K, Mosbah K, et al. Hyperpolarized 3He MR for sensitive imaging of ventilation function and treatment efficiency in young cystic fibrosis patients with normal lung function. Radiology 2010;255:225-32.
3. de Jong PA, Nakano Y, Lequin MH, et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004;23:93-7.
4. Horsley A, Wild JM. Ventilation heterogeneity and the benefits and challenges of multiple breath washout testing in patients with cystic fibrosis. Paediatr Respir Rev 2015;16(Suppl 1):15-18.
5. Loeve M, Lequin MH, de Bruijne M, et al. Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease? Radiology 2009;253:223-9.
6. Gustafsson PM, Aurora P, Lindblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003;22:972-9.
7. Horsley AR, Macleod KA, Robson AG, et al. Effects of cystic fibrosis lung disease on gas mixing indices derived from alveolar slope analysis. Respir Physiol Neurobiol 2008;162:197-203.
8. Rosenow T, Oudraad MC, Murray CP, et al., Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). PRAGMA-CF. A quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis. Am J Respir Crit Care Med 2015;191:1158-65.
9. Davies J, Sheridan H, Bell N, et al. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. Lancet Respir Med 2013;1:630-8.
10. Stewart NJ, Norquay G, Griffiths PD, et al. Feasibility of human lung ventilation imaging using highly polarized naturally abundant xenon and optimized three-dimensional steady-state free precession. Magn Reson Med 2015;74:346-52.